Two Sigma Advisers
EIGR

Two Sigma Advisers’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Two Sigma Advisers’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,525
Closed -$54K – 2792
2022
Q4 		$54K Buy
1,525
+663
+77% +$79.6K ﹤0.01% 2356
2022
Q3 		$195K Buy
862
+522
+154% +$128K ﹤0.01% 2210
2022
Q2 		$64K Sell
340
-60
-15% -$12.1K ﹤0.01% 2452
2022
Q1 		$100K Sell
400
-715
-64% -$113K ﹤0.01% 2505
2021
Q4 		$174K Sell
1,115
-2,576
-70% -$498K ﹤0.01% 2316
2021
Q3 		$740K Sell
3,691
-2,167
-37% -$515K ﹤0.01% 1755
2021
Q2 		$1.5M Sell
5,858
-5,460
-48% -$1.36M ﹤0.01% 1443
2021
Q1 		$3M Sell
11,318
-1,703
-13% -$537K 0.01% 1074
2020
Q4 		$4.8M Buy
13,021
+2,143
+20% +$615K 0.01% 836
2020
Q3 		$2.66M Buy
10,878
+1,990
+22% +$619K 0.01% 1024
2020
Q2 		$2.56M Buy
8,888
+1,337
+18% +$394K 0.01% 1082
2020
Q1 		$1.54M Buy
7,551
+5,163
+216% +$1.65M 0.01% 1251
2019
Q4 		$1.07M Buy
2,388
+1,813
+315% +$643K ﹤0.01% 1546
2019
Q3 		$177K Sell
575
-280
-33% -$91K ﹤0.01% 2064
2019
Q2 		$272K Buy
855
+284
+50% +$98.3K ﹤0.01% 2044
2019
Q1 		$240K Buy
+571
New +$229K ﹤0.01% 2059
2016
Q1 		– Sell
-215
Closed -$142K – 2163
2015
Q4 		$142K Sell
215
-11
-5% -$6.22K ﹤0.01% 1734
2015
Q3 		$109K Sell
226
-97
-30% -$51.5K ﹤0.01% 1714
2015
Q2 		$183K Buy
323
+295
+1,054% +$816K ﹤0.01% 1760
2015
Q1 		$237K Buy
+28
New +$245K ﹤0.01% 1678

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers's EIGR Position: Q1 2023 in Review

Two Sigma Advisers sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2023, closing a stake of 1,525 shares — an estimated $54K sold.

Two Sigma Advisers first reported a position in EIGR in Q1 2015 and held it in 20 quarters. The position peaked at $4.8M in Q4 2020. 71 funds tracked by Wall St. Rank hold EIGR as of Q1 2023.

  • Two Sigma Advisers reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 1,525 Eiger BioPharmaceuticals, Inc. shares in Q1 2023, an estimated $54K.
  • Two Sigma Advisers first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2015 and held it in 20 quarters.
  • Two Sigma Advisers's Eiger BioPharmaceuticals, Inc. position peaked at $4.8M in Q4 2020.
  • 71 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.